Pfizer-BioTech seek vaccine OK for children
The Hindu
Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies' coronavirus vaccine to include children ages 12 to 15, a move that could of
Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies' coronavirus vaccine to include children ages 12 to 15, a move that could offer younger and less at-risk populations in Europe access to the shots for the first time. In a statement on Friday, the two companies said their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective. The children will continue to be monitored for longer-term protection and safety for another two years. BioNTech and Pfizer previously had requested their emergency use authorisation with the U.S. Food and Drug Administration also be extended to children 12-15.More Related News
Everyone talks about the Airport Metro, but one look at the pillars and completion seems nowhere in sight. Meanwhile, a faster, cheaper, roomier alternative called the Suburban Rail Airport Corridor is finally getting off the drawing board. This dedicated corridor with its specialised coaches will link the airport to vast stretches of Bengaluru, where the metro connection is still years away.